Key result
Post-MI secondary prevention prescribing is high, reaching ~97% for aspirin mostly initiated at discharge.
Why the study?
Clinical trials have shown secondary prevention after myocardial infarction is effective, but implementation in routine practice may be inadequate.
What are the implementation rates of evidence-based secondary prevention measures in routine clinical practice for patients surviving an acute myocardial infarction?
Cohort (n=608)
What are the implementation rates of evidence-based secondary prevention measures in routine clinical practice for patients surviving an acute myocardial infarction?
Hospital-initiated prescribing achieves high rates of adherence to evidence-based drug therapy for secondary prevention after myocardial infarction, though lifestyle advice provision remains suboptimal.
Answers are grounded in this paper and cite their sources.
Incomplete adoption of lifestyle advice and monitoring persists post-MI; leaves open whether coordinated primary-secondary care improves implementation.
Objectives: Clinical trials have demonstrated that secondary prevention of myocardial infarction is effective, but several studies have suggested that research findings are not adequately implemented in routine clinical practice. This study aimed to determine whether these findings are now being more fully implemented.Methods: A cohort of 608 patients aged less than 80 years, surviving more than 28 days after an acute myocardial infarction, was identified from a population of 568,000 people in Oxfordshire, UK, during a 12-month period from November 1994. The MONICA Project diagnostic criteria for definite or possible myocardial infarction were used to define cases. Hospital and general practice casenotes were reviewed and survivors were asked to complete a questionnaire.Results: Among patients without contraindications to treatment, 430 were prescribed aspirin (97%), 277 β-blockers (66%), and 77 ACE inhibitors (85%) in the first three months after the acute event. Of these drugs, 705 (90%) were prescribed on discharge from hospital. Reliable cholesterol measurements were available for 307 patients (51%). Advice on physical activity was offered to 275 patients (45%), dietary advice to 172 (50% of patients with a total cholesterol concentration ≥5.5 mmol/l), and smoking cessation advice to 62 (37% of smokers). There were no differences in drug prescription rates between men and women, but women overall were significantly less likely to receive smoking cessation advice and older women, aged 60-79, were less likely to receive advice on physical activity.Conclusions:: Optimal follow-up of patients after a myocardial infarction requires a coordinated strategy between primary and secondary care. Hospital-initiated prescribing can achieve higher rates of adherence to evidence-based recommendations for drug therapy for the secondary prevention of myocardial infarction than has previously been reported. Systematic followup in general practice is needed to identify any deficiencies in hospital care, to monitor long-term therapy, and to reinforce lifestyle advice.
No takes yet. Share an insight, caveat, or question.
Dovey et al. (1998) conducted a cohort in Myocardial Infarction (n=608). Secondary prevention guidelines implementation was evaluated on Prescription rates of secondary prevention medications and lifestyle advice. In a cohort of 608 post-myocardial infarction patients, secondary prevention prescribing was high, mostly initiated at discharge.
Synapse has enriched 10 related papers. Consider them for comparative context: